Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft
Authors:
Open Access
- 1 January 2000
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 82 (2) , 480-487
Abstract
Astrocytes harbour functional receptors to many neurotransmitters, including substance P (SP), an undecapeptide belonging to the tachykinin family of peptide transmitters. SP activates malignant glial cells to induce cytokine release and proliferation, both responses being relevant for tumour progression. In tumours developed in nude mice transplanted subcutaneously (s.c.) to U373 MG human glioma cells, the presence of SP was observed at immunohistochemistry. Although the administration of exogenous SP did not significantly affect the size or development of U373 MG xenograft, a role of SP in supporting glioma progression in vivo was highlighted by the tumour growth inhibition induced by highly specific and selective human tachykinin NK1receptor antagonists (MEN 11467 and MEN 11149). The anti-tumour activity of MEN 11467 was observed both with s.c. or intravenous treatments and was partially reverted by the concomitant administration of exogenous SP. Doxorubicin did not show any activity in controlling U373 MG growth in this in vivo model. A novel therapeutic approach to treat malignant gliomas with tachykinin NK1receptor antagonists is suggested by these findings. © 2000 Cancer Research CampaignKeywords
This publication has 28 references indexed in Scilit:
- Glial-cell-line-derived neurotrophic factor enhances biosynthesis of substance P in striatal neurons in vitroCell and tissue research, 1996
- Interleukin-6 production by U373 MG, a human astrocytoma cell line: different pathways involved in substance P and lipopolysaccharide activationJournal of Neuroimmunology, 1995
- Substance‐P receptors in human primary neoplasms: Tumoral and vascular localizationInternational Journal of Cancer, 1995
- Gene transfer of human TNFα into glioblastoma cells permits modulation of mdr1 expression and potentiation of chemosensitivityInternational Journal of Cancer, 1995
- Interleukin-6 secretion from human astrocytoma cells induced by substance PJournal of Neuroimmunology, 1994
- Involvement of Nitric Oxide on the Cytokine-Induced Growth of Glial CellBiochemical and Biophysical Research Communications, 1993
- Characterization of a Human NK1 Tachykinin Receptor in the Astrocytoma Cell Line U 373 MGJournal of Neurochemistry, 1993
- Tachykinin receptors and tachykinin receptor antagonistsJournal of Autonomic Pharmacology, 1993
- TGFβ1 and TGFβ2 are potential growth regulators for low‐grade and malignant gliomas in vitro: Evidence in support of an autocrine hypothesisInternational Journal of Cancer, 1991
- Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cellsMicrovascular Research, 1990